Yakira Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-155,177
| Closed | -$133K | – | 187 |
|
|
2019
Q4 | $133K | Hold |
155,177
| – | – | 0.04% | 121 |
|
|
2019
Q3 | $87K | Hold |
155,177
| – | – | 0.03% | 130 |
|
|
2019
Q2 | $81K | Hold |
155,177
| – | – | 0.02% | 129 |
|
|
2019
Q1 | $70K | Hold |
155,177
| – | – | 0.02% | 109 |
|
|
2018
Q4 | $74K | Hold |
155,177
| – | – | 0.02% | 107 |
|
|
2018
Q3 | $82K | Hold |
155,177
| – | – | 0.02% | 122 |
|
|
2018
Q2 | $78K | Hold |
155,177
| – | – | 0.02% | 113 |
|
|
2018
Q1 | $66K | Hold |
155,177
| – | – | 0.02% | 116 |
|
|
2017
Q4 | $59K | Hold |
155,177
| – | – | 0.02% | 100 |
|
|
2017
Q3 | $56K | Hold |
155,177
| – | – | 0.02% | 108 |
|
|
2017
Q2 | $59K | Hold |
155,177
| – | – | 0.02% | 100 |
|
|
2017
Q1 | $70K | Hold |
155,177
| – | – | 0.03% | 93 |
|
|
2016
Q4 | $59K | Hold |
155,177
| – | – | 0.03% | 75 |
|
|
2016
Q3 | $42K | Hold |
155,177
| – | – | 0.01% | 75 |
|
|
2016
Q2 | $37K | Hold |
155,177
| – | – | 0.01% | 101 |
|
|
2016
Q1 | $18K | Hold |
155,177
| – | – | 0.01% | 111 |
|
|
2015
Q4 | $17K | Hold |
155,177
| – | – | ﹤0.01% | 115 |
|
|
2015
Q3 | $30K | Sell |
155,177
-9,300
| -6% | -$3.16K | 0.02% | 118 |
|
|
2015
Q2 | $115K | Hold |
164,477
| – | – | 0.06% | 107 |
|
|
2015
Q1 | $112K | Hold |
164,477
| – | – | 0.08% | 76 |
|
|
2014
Q4 | $130K | Hold |
164,477
| – | – | 0.1% | 80 |
|
|
2014
Q3 | $76K | Hold |
164,477
| – | – | 0.06% | 89 |
|
|
2014
Q2 | $82K | Hold |
164,477
| – | – | 0.06% | 99 |
|
|
2014
Q1 | $51K | Hold |
164,477
| – | – | 0.05% | 78 |
|
|
2013
Q4 | $56K | Buy |
+164,477
| New | +$199K | 0.06% | 84 |
|
Yakira Capital Management's GCVRZ Position: Q1 2020 in Review
Yakira Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 155,177 shares — an estimated $133K sold.
Yakira Capital Management first reported a position in GCVRZ in Q4 2013 and held it in 25 quarters. The position peaked at $133K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Yakira Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Yakira Capital Management sold 155,177 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $133K.
- Yakira Capital Management first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 25 quarters.
- Yakira Capital Management's Sanofi Contingent Value Rights position peaked at $133K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Yakira Capital Management's 13F filing for Q1 2020, filed 14 May 2020.